Australian Securities and Investments Commission v Blumenthal [2024] FCA 384

Australian Securities and Investments Commission v Blumenthal [2024] FCA 384

The defendant, a director and controlling mind of EverBlu Capital Pty Ltd and Creso Pharma Ltd, contravened ss 180(1) and 181(1)(a) of the Corporations Act by breaching directors' duties, failing to avoid conflicts of interest, and participating in transactions that created a false or misleading appearance of active...

Source-derived case information.

Jurisdiction
Australia
Judgment Date
12 April 2024
Procedural Posture
Civil / Judgment on Penalty, Disqualification, and Interlocutory Application
Outcome
Declarations of contravention, five-year disqualification, pecuniary penalty, costs and partial leave to manage.
Legal Topics
["directors' Duties" 'market Misconduct' 'disqualification of Directors' 'civil Penalties' 'financial Services Regulation']
['corporations' 'commercial Law' 'banking and Finance Law'] ["directors' Duties" 'market Misconduct' 'disqualification of Directors' 'civil Penalties' 'financial Services Regulation']

Source-derived case record

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Procedural Posture

Civil / Judgment on Penalty, Disqualification, and Interlocutory Application

Legal Issues

  1. 1 ["Whether the defendant contravened directors' duties under the Corporations Act 2001 (Cth)" 'Whether the defendant engaged in conduct creating a false or misleading appearance of active trading in financial products' 'Whether the defendant should be disqualified from managing corporations' 'Appropriate penalty for admitted contraventions' 'Whether leave should be granted under s 206G for limited management roles during disqualification']

Ratio Decidendi

The defendant, a director and controlling mind of EverBlu Capital Pty Ltd and Creso Pharma Ltd, contravened ss 180(1) and 181(1)(a) of the Corporations Act by breaching directors' duties, failing to avoid conflicts of interest, and participating in transactions that created a false or misleading appearance of active trading in Creso shares, in further breach of s 1041B(1)(b). The admitted conduct was serious, interrelated, and justified declaratory relief, a five-year disqualification from managing corporations, an $850,000 pecuniary penalty, and cost orders. Leave to manage two family companies during disqualification was appropriate with strict limitations to mitigate public and...

Court Disposition

Declarations of contravention, five-year disqualification, pecuniary penalty, costs and partial leave to manage.

Orders

  • ['Declaration that defendant contravened ss 180(1), 181(1)(a), and 1041B(1)(b) of the Corporations Act' 'Disqualification from managing corporations for 5 years under s 206C' 'Pecuniary penalty of $850,000 to the Commonwealth of Australia under s 1317G' "Order to pay plaintiff's litigation costs of $100,000 within...